Modern, antibodies persist 6 months after second dose – Last Hour

(ANSA) – ROME, APRIL 08 – Antibodies induced by Moderna’s Covid vaccine persist 6 months after the second dose of the vaccine (mRNA-1273). The pharmaceutical company communicates it. The data are published in the Letter to Editor of the New England Journal of Medicine. The most recent results, Moderna says, indicate that mRNA-1273-activated antibodies are present 6 months after the second dose. The study analyzed 33 healthy adults who participated in the NIH-led phase 1 study of Moderna’s Covid-19 vaccine. Studies are ongoing that monitor immune responses beyond 6 months.

“We are delighted that these new data show the persistence of antibodies for 6 months after the second dose of our Covid-19 vaccine,” said Stéphane Bancel, CEO of Moderna. This, he stressed, “gives us further confidence in the protection offered by our vaccine. We remain committed to continuing to tackle the Covid-19 pandemic.”

Moderna, the same company says in a statement, “is also pursuing a clinical development strategy against emerging variants.” In addition, NIAID, part of the National Institutes of Health (NIH), “will conduct a Phase 1 clinical trial to evaluate monovalent and multivalent modified mRNA-1273 vaccines as a primary series in naïve individuals and as a booster vaccine in those previously vaccinated with mRNA-1273 “. (HANDLE).

Get the latest news delivered to your inbox

Follow us on social media networks

PREV Luce, from 30 September only one request for the transfer and change of supplier –
NEXT Bills bonus, rules for VAT numbers from ARERA